QUEST DIAGNOSTICS INCORPORATED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 140.7 USD | +1.13% |
|
+3.43% | +2.13% |
| 07:49pm | Argus Raises Quest Diagnostics' Price Target to $163 From $155 | MT |
| 05-06 | Quest Diagnostics Appoints Murali Balakumar as Senior Vice President and Chief Information and Digital Officer | CI |
Presenter SpeechShawn Bevec (Executives)Good morning. I'm Shawn Bevec, Vice President of Inve...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Calendar
2024-05-16
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
139.2
USD
Average target price
146.7
USD
Spread / Average Target
+5.44%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.13% | 15.46B | |
| -29.36% | 70.3B | |
| +2.04% | 27.46B | |
| -6.54% | 17.8B | |
| +2.32% | 17.46B | |
| +6.85% | 13.49B | |
| +10.80% | 13.06B | |
| +72.49% | 12.96B | |
| +74.00% | 12.56B | |
| +1.87% | 12.14B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Transcript : Quest Diagnostics Incorporated - Analyst/Investor Day
